Hsbc Holdings PLC Corcept Therapeutics Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 54,403 shares of CORT stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,403

Previous 108,366 49.8%

Holding current value

$2.72 Million

Previous $3.52 Million 28.52%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $1.59 Million - $2.5 Million	-53,963 Reduced 49.8%	54,403 $2.52 Million
Q2 2024 Aug 12, 2024	BUY	$22.21 - $34.48 $617,104 - $958,026	27,785 Added 34.48%	108,366 $3.52 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $720,607 - $937,813	34,152 Added 73.56%	80,581 $2.03 Million
Q4 2023 Feb 12, 2024	BUY	$24.82 - $32.88 $505,335 - $669,436	20,360 Added 78.1%	46,429 $1.51 Million
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $87,726 - $134,963	3,993 Added 18.09%	26,069 $710,000
Q2 2023 Aug 11, 2023	SELL	$21.44 - $25.15 $14.1 Million - $16.6 Million	-659,002 Reduced 96.76%	22,076 $491,000
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $12.1 Million - $15.5 Million	632,443 Added 1300.39%	681,078 $14.8 Million
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $302,302 - $453,983	15,153 Added 45.26%	48,635 $987,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $379,268 - $447,137	15,355 Added 84.71%	33,482 $872,000
Q2 2022 Aug 11, 2022	SELL	$17.33 - $25.3 $58,194 - $84,957	-3,358 Reduced 15.63%	18,127 $434,000
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $58,764 - $89,621	-3,555 Reduced 14.2%	21,485 $484,000
Q4 2021 Feb 11, 2022	BUY	$17.1 - $23.34 $154,618 - $211,040	9,042 Added 56.52%	25,040 $495,000
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $132,702 - $151,919	-6,743 Reduced 29.65%	15,998 $316,000
Q2 2021 Aug 13, 2021	BUY	$19.97 - $24.43 $141,088 - $172,597	7,065 Added 45.07%	22,741 $500,000
Q1 2021 May 14, 2021	BUY	$23.49 - $30.56 $33,167 - $43,150	1,412 Added 9.9%	15,676 $372,000
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $239,349 - $389,407	14,264 New	14,264 $373,000
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $224,726 - $316,032	-18,634 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $193,979 - $273,174	18,634 New	18,634 $263,000

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.35B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Corcept Therapeutics Inc Transaction History